CuraMe is the AI-powered operational co-pilot for Italian general practitioners. SegretAI drafts. The doctor decides. 25 hours per month recovered from administrative work — at €30 per month.
Forty-eight years old. Lombardy. Twenty-two years of practice. Eight in the same office. Today she opens her laptop at 7:48 in the morning.
The 1,500-patient ceiling was created to protect care quality. It is now routinely waived so the system doesn't collapse.
Forty messages a day. Prescription requests. Referral letters. Reports to summarise. Lab results to communicate. WhatsApp. Email. Phone. Different channels. Same patient. No single inbox.
Across the country, this scales to a labor shortage no replacement pipeline can fill. The workforce isn't growing; the demand is. The curves crossed five years ago.
An operational co-pilot that drafts the asynchronous, ingests the documents, holds the continuity — and lets the physician do what only the physician can do.
Italy has the second-oldest population in Europe and one of the highest demand pressures on primary care. It also has a contracting GP workforce. These two curves crossed five years ago. They will not uncross before 2030. This is not a cyclical problem.
Same patient inbox at 8:14 AM. Same forty messages. On the left, the world a GP knows in 2026 — fragmented channels, parallel queues, no continuity. On the right, the same workload through CuraMe — unified, drafted, audit-logged.
A patient writes. SegretAI prepares a complete draft, including the appropriate clinical detail and the GP's own tone profile. The doctor edits if needed, then sends. Every action is logged. Every clinical decision remains the physician's.
CuraMe is not a marketplace. Not a telemedicine app. Not an AI scribe. It is the daily-workflow co-pilot that lets an Italian GP and their patients stay continuously connected — without either of them changing how they work.
The orchestration layer between patient and doctor.
These are not marketing numbers. They are derived from time-and-motion observations on the first 50 GPs using CuraMe in real practice. Adjust the assumptions to your own scenario.
The fair objection in 2026: in an age of general-purpose AI, what makes CuraMe defensible? The answer is that the binding constraints in Italian primary care are not technological. They are trust, regulation, language, and embedded workflow. Click each card to dig deeper.
Italian GPs adopt tools through associations, peer networks, and accredited CME — not paid ads.
Embedded in the daily inbox via PMS integrations. Switching cost is measured in lost time.
EU residency, GDPR Art.9, AI Act human-in-the-loop by design. 6–9 months of compliance engineering.
Italian GP–patient interactions are a corpus no foundation model has and cannot acquire.
Patient brings retention pressure on the GP; GP brings credibility on the patient.
CuraMe drafts; the doctor decides. We will not ship features that bypass clinical judgement, regardless of what becomes technically possible.
Custodianship, not ownership. Portability and deletion are first-class product features, not afterthoughts.
No dark patterns, no engagement-maxing nudges. If a feature doesn't recover GP time or improve patient continuity, it doesn't ship.
Italy is acute today. France, Spain, and Germany are 3–5 years behind on the same curve. Five priority regions concentrate 45% of our serviceable addressable market. Hover the map.
Not a pitch deck. Real GPs running real practices with CuraMe inside their daily workflow today. The first cohort behaves like the model expects — only better on the churn axis.
Commercial & growth background in digital health and fintech. Runs the commercial engine and the founder-led onboarding of the first 50 GPs.
Owns the entire technical stack — GP web app, patient mobile app, SegretAI orchestrator, EU-resident compliance architecture.
The pitch is a starting point — not an ending. We want investors and partners who will challenge assumptions, push back on the model, and ask the awkward questions. Reach out.